Arginine deiminase enhances MCF-7 cell radiosensitivity by inducing changes in the expression of cell cycle-related proteins

Molecules and Cells

Volumn 25, Issue 2, 2008, Pages 305-311

  Park, Hwan ^a   Lee, Jun Beom ^a   Shim, Young Jun ^a   Shin, Yong Jae ^a   Jeong, Seong Yun ^a   Oh, Junseo ^b   Park, Gil Hong ^b   Lee, Kee Ho ^c   Min, Bon Hong ^a  

^a Korea University   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Korea Institute of Radiation and Medical Science   (South Korea)

Author keywords

ADI; ASS; c Myc; IR; p21

Indexed keywords

AMMONIA; ARGININE; ARGININE DEIMINASE; ARGININOSUCCINATE SYNTHASE; CELL CYCLE PROTEIN; CITRULLINE; CYCLIN DEPENDENT KINASE INHIBITOR; MYC PROTEIN; PROTEIN P21;

ARTICLE; CANCER THERAPY; CELL CYCLE; CELL DEATH; CELL GROWTH; CELL STRAIN MCF 7; CLONOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; GROWTH INHIBITION; HEPATOMA CELL; HUMAN; HUMAN CELL; IONIZING RADIATION; MYCOPLASMA; PROTEIN EXPRESSION; RADIOSENSITIVITY;

AMMONIA; ARGININOSUCCINATE SYNTHASE; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROLASES; MYCOPLASMA; PROTO-ONCOGENE PROTEINS C-MYC; RADIATION TOLERANCE; RADIATION, IONIZING;

MYCOPLASMA;

EID: 44949240553     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Akie, K., Dosaka-Akita, H., Murakami, A., and Kawakami, Y. (2000). A combination treatment of c-myc antisense DNA with all-trans-retinoic acid inhibits cell proliferation by downregulating c-myc expression in small cell lung cancer. Antisense Nucleic Acid Drug Dev. 10, 243-249.
2. Arundel, C.M., Nishioka, K., and Tofilon, P.J. (1988). Effects of alpha-difluoromethylomithine-induced polyamine depletion on the radiosensitivity of a human colon carcinoma cell line. Radiat. Res. 114, 634-640.
3. Brune, B., Hartzell, P., Nicotera, P., and Orrenius, S. (1991). Spermine prevents endonuclease activation and apoptosis in thymocytes. Exp. Cell Res. 195, 323-329.
4. Chinnaiyan, A.M., Prasad, U., Shankar, S., Hamstra, D.A., Shanaiah, M., Chenevert, T.L., Ross, B.D., and Rehemtulla, A. (2000). Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc. Natl. Acad. Sci. USA 97, 1754-1759.
5. Courdi, A., Milano, G., Bouclier, M., and Lalanne, C.M. (1986). Radiosensitization of human tumor cells by alpha-difluoro methylornithine. Int. J. Cancer 38, 103-107.
6. Ebinuma, H., Saito, H., Saito, Y., Wakabayashi, K., Nakamura, M., Kurose, I., and Ishii, H. (1999). Antisense oligodeoxynucleotide against c-myc mRNA induces differentiation of human hepatocellular carcinoma cells. tnt. J. Oncol. 15, 991-999.
7. Gartel, A.L., and Radhakrishnan, S.K. (2005). Lost in transcription: p21 repression, mechanisms, and consequences. Cancer Res. 65, 3980-3985.
8. Gong, H., Pottgen, C., Stuben, G., Havers, W., Stuschke, M., and Schweigerer, L. (2003). Arginine deiminase and other antiangiogenic agents inhibit unfavorable neuroblastoma growth: potentiation by irradiation. Int. J. Cancer 106, 723-728.
9. Guan, X.X., Chen, L.B., Ding, G.X., De, W., and Zhang, A.H. (2004). Transfection of p27kip1 enhances radiosensitivity induced by 60Co gamma-irradiation in hepatocellular carcinoma HepG2 cell line. World J. Gastroenterol. 10, 3103-3106.
10. Hipfner, D.R., and Cohen, S.M. (2004). Connecting proliferation and apoptosis in development and disease. Nat. Rev. Mol. Cell Biol. 5, 805-815.
11. Holle, L.M. (1997). Pegaspargase: an alternative? Ann. Pharmacother. 31, 616-624.
12. Hortobagyi, G.N., Ames, F.C., Buzdar, A.U., Kau, S.W., McNeese, M.D., Paulus, D., Hug, V., Holmes, F.A., Romsdahl, M.M., Fraschini, G., et al. (1988). Management of stage III primary breast cancer with primary chemotherapy, surgery, and radiation therapy. Cancer 62, 2507-2516.
13. Kang, Y., Cortina, R., and Perry, R.R. (1996). Role of c-myc in tamoxifen-induced apoptosis estrogen-independent breast cancer cells. J. Natl. Cancer Inst. 88, 279-284.
14. Kang, S.W., Kang, H., Park, I.S., Choi, S.H., Shin, K.H., Chun, Y.S., Chun, B.G., and Min, B.H. (2000). Cytoprotective effect of arginine deiminase on taxol-induced apoptosis in DU145 human prostate cancer cells. Mol. Cells 10, 331-337.
15. Khan, A.U., Di Mascio, P., Medeiros, M.H., and Wilson, T. (1992). Spermine and spermidine protection of plasmid DNA against single-strand breaks induced by singlet oxygen. Proc. Natl. Acad. Sci. USA 89, 11428-11430.
16. Le, X.F., Pruefer, F., and Bast, R.C., Jr. (2005). HER2-targeting antibodies modulate the cyclin-dependent kinase inhibitor p27Kip1 via multiple signaling pathways. Cell Cycle 4, 87-95.
17. Li, A., and Blow, J.J. (2001). The origin of CDK regulation. Nat. Cell Biol. 3, E182-184.
18. Liao, D.J., and Dickson, R.B. (2000). c-Myc in breast cancer. Endocr. Relat. Cancer 7, 143-164.
19. Little, F.A. (1994). Pacemakers in radiotherapy. Clin. Oncol. (R Coll Radiol) 6, 211-212.
20. Maity, A., Kao, G.D., Muschel, R.J., and McKenna, W.G. (1997). Potential molecular targets for manipulating the radiation response. Int. J. Radiat. Oncol. Biol. Phys. 37, 6397-653.
21. Noh, E.J., Kang, S.W., Shin, Y.J., Kim, D.C., Park, I.S., Kim, M.Y., Chun, B.G., and Min, B.H. (2002). Characterization of mycoplasma arginine deiminase expressed in E. coli and its inhibitory regulation of nitric oxide synthesis. Mol. Cells 13, 137-143.
22. Noh, E.J., Kang, S.W., Shin, Y.J., Choi, S.H., Kim, C.G., Park, I.S., Wheatley, D.N., and Min, B.H. (2004). Arginine deiminase enhances dexamethasone-induced cytotoxicity in human T-lymphoblastic leukemia CCRF-CEM cells. Int. J. Cancer 112, 502-508.
23. Ryu, M.R., Paik, S.Y., and Chung, S.M. (2005). Combined effect of heptaplatin and ionizing radiation on human squamous carcinoma cell lines. Mol. Cells 19, 143-148.
24. Sahu, S., Saika, S., Pai, S.K., and Advani, S.H. (1998). L-asparaginase (Leunase) induced pancreatitis in childhood acute lymphoblastic leukemia. Pediatr. Hematol. Oncol. 15, 533-538.
25. Shen, L.J., Lin, W.C., Beloussow, K., and Shen, W.C. (2003). Resistance to the anti-proliferative activity of recombinant arginine deiminase in cell culture correlates with the endogenous enzyme, argininosuccinate synthetase. Cancer Lett. 191, 165-170.
26. Sherr, C.J., and Roberts, J.M. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501-1512.
27. Snyder, R.D., and Schroeder, K.K. (1994). Radiosensitivity of polyamine-depleted HeLa cells and modulation by the aminothiol WR-1065. Radiat. Res. 137, 67-75.
28. Takaku, H., Takase, M., Abe, S., Hayashi, H., and Miyazaki, K. (1992). In vivo anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int. J. Cancer 51, 244-249.
29. van Rijn, J., van den Berg, J., Teerlink, T., Kruyt, F.A., Schor, D.S., Renardel de Lavalette, A.C., van den Berg, T.K., Jakobs, C., and Slotman, B.J. (2003). Changes in the ornithine cycle following ionising radiation cause a cytotoxic conditioning of the culture medium of H35 hepatoma cells. Br. J. Cancer 88, 447-454.
30. van Rijn, J., van den Berg, J., Schipper, R.G., de Jong, S., Cuijpers, V., Verhofstad, A.A., and Teerlink, T. (2004). Induction of hyperammonia in irradiated hepatoma cells: a recapitulation and possible explanation of the phenomenon. Br. J. Cancer 91, 150-152.
31. Watson, P.H., Pon, R.T., and Shiu, R. P. (1991). Inhibition of c-myc expression by phosphorothioate antisense oligonucleotide identifies a critical role for c-myc in the growth of human breast cancer. Cancer Res. 51, 3996-4000.
32. Wu, G., and Morris, S.M., Jr. (1998). Arginine metabolism-nitric oxide and beyond. Biochem. J. 336 (Pt 1), 1-17.
33. Yoon, C.Y., Shim, Y.J., Kim, E.H., Lee, J.H., Won, N.H., Kim, J.H Park, I.S., Yoon, D.K., and Min, B.H. (2007). Renal cell carcinoma does not express argininosuccinate synthetase and is highly sensitive to arginine deprivation via arginine deiminase. Int. J. Cancer 120, 897-905.
34. Zhivotovsky, B., Joseph, B., and Orrenius, S. (1999). Tumor radiosensitivity and apoptosis. Exp. Cell Res. 248, 10-17.